High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial

Published:2015-04-07 Issue:4 Volume:10 Page:e0120228
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hoffer L. John,Robitaille Line,Zakarian Robert,Melnychuk David,Kavan Petr,Agulnik Jason,Cohen Victor,Small David,Miller Wilson H.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. Vitamin C in alternative cancer treatment: historical background;KI Block;Integ Cancer Ther,2003

2. Roundtable: Intravenous Vitamin C for Treating Cancer;J Challem;Alt Complement Ther,2009

3. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects;SJ Padayatty;PLoS ONE,2010

4. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo;Q Chen;Proc Natl Acad Sci USA,2007

5. High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis;CH Yeom;J Transl Med,2009

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy;Clinical and Translational Oncology;2024-09-11

2. Pharmacologic ascorbate induces transient hypoxia sensitizing pancreatic ductal adenocarcinoma to a hypoxia activated prodrug;Free Radical Biology and Medicine;2024-09

3. Pharmacological Ascorbate Induces Transient Hypoxia Sensitizing Pancreatic Ductal Adenocarcinoma to a Hypoxia Activated Prodrug;2024-05-15

4. The Involvement of Ascorbic Acid in Cancer Treatment;Molecules;2024-05-13

5. Micronutrient Status and Breast Cancer: A Narrative Review;International Journal of Molecular Sciences;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3